BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H, Gonzalez-Vicent M, Espigado I, Halter J, Martino R, Mohty B, Sucak G, Ullmann AJ, Vázquez L, Ward KN, Engelhard D; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation., Infectious Complications Subcommittee, Spanish Group of Haematopoietic Stem-cell Transplantation. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 2011;96:1231-5. [PMID: 21546495 DOI: 10.3324/haematol.2011.041913] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Ljungman P. Vaccination of immunocompromised hosts. Vaccines. Elsevier; 2013. pp. 1243-56. [DOI: 10.1016/b978-1-4557-0090-5.00016-1] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
2 Herold S, Becker C, Ridge KM, Budinger GR. Influenza virus-induced lung injury: pathogenesis and implications for treatment. Eur Respir J 2015;45:1463-78. [PMID: 25792631 DOI: 10.1183/09031936.00186214] [Cited by in Crossref: 174] [Cited by in F6Publishing: 170] [Article Influence: 24.9] [Reference Citation Analysis]
3 Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, de Lavallade H, Gallo G, Lehrnbecher T, Engelhard D, Ljungman P; European Conference on Infections in Leukaemia group. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 2019;19:e200-12. [PMID: 30744963 DOI: 10.1016/S1473-3099(18)30600-5] [Cited by in Crossref: 76] [Cited by in F6Publishing: 30] [Article Influence: 25.3] [Reference Citation Analysis]
4 Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C, Roccia-Rossi I, Stecher D, Carbone E, Laborde A, Efron E, Altclas J, Calmaggi A, Cozzi J. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res 2014;3:221. [PMID: 25469231 DOI: 10.12688/f1000research.5251.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
5 Gooskens J, Marijt WA, van Essen EH, Rimmelzwaan GF, Kroes AC. Host immunity dictates influenza A(H1N1)pdm09 infection outcome in hematology-oncology patients. Bone Marrow Transplant 2016;51:138-41. [PMID: 26389836 DOI: 10.1038/bmt.2015.214] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Pochon C, Voigt S. Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients. Front Microbiol 2018;9:3294. [PMID: 30687278 DOI: 10.3389/fmicb.2018.03294] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
7 Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2013;15:487-92. [PMID: 23890293 DOI: 10.1111/tid.12116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
8 Ison MG, Hay A. Antivirals: Targets and use. In: Webster RG, Monto AS, Braciale TJ, Lamb RA, editors. Textbook of Influenza. Oxford: John Wiley & Sons, Ltd; 2013. pp. 392-418. [DOI: 10.1002/9781118636817.ch25] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 El Ramahi R, Freifeld A. Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients. J Oncol Pract 2019;15:177-84. [PMID: 30970229 DOI: 10.1200/JOP.18.00567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
10 de la Cámara R. Vaccinations. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook. Cham: Springer International Publishing; 2019. pp. 207-19. [DOI: 10.1007/978-3-030-02278-5_29] [Reference Citation Analysis]
11 Cherif H, Höglund M, Pauksens K. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients. Eur J Haematol 2013;90:413-9. [DOI: 10.1111/ejh.12094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
12 Arslan D, Danziger-Isakov L. Respiratory viral infections in pediatric solid organ and hematopoietic stem cell transplantation. Curr Infect Dis Rep 2012;14:658-67. [PMID: 22968439 DOI: 10.1007/s11908-012-0294-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
13 Fukatsu Y, Nagata Y, Adachi M, Yagyu T, Ono T. Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation. Int J Hematol 2017;105:638-45. [DOI: 10.1007/s12185-016-2163-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
14 Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P; Haemato-oncology Task Force of the British Committee for Standards in Haematology., British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network. BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. Br J Haematol 2016;173:380-93. [PMID: 27060988 DOI: 10.1111/bjh.14027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
15 Hermann B, Lehners N, Brodhun M, Boden K, Hochhaus A, Kochanek M, Meckel K, Mayer K, Rachow T, Rieger C, Schalk E, Weber T, Schmeier-Jürchott A, Schlattmann P, Teschner D, von Lilienfeld-Toal M. Influenza virus infections in patients with malignancies -- characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis 2017;36:565-73. [PMID: 27838792 DOI: 10.1007/s10096-016-2833-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
16 Seo S, Xie H, Campbell AP, Kuypers JM, Leisenring WM, Englund JA, Boeckh M. Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome. Clin Infect Dis 2014;58:1357-68. [PMID: 24599766 DOI: 10.1093/cid/ciu134] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 10.4] [Reference Citation Analysis]
17 Loubet P, Loulergue P, Galtier F, Launay O. Seasonal influenza vaccination of high-risk adults. Expert Rev Vaccines 2016;15:1507-18. [PMID: 27169689 DOI: 10.1080/14760584.2016.1188696] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
18 Shankaran S, Bearman GML. Influenza Virus Resistance to Neuraminidase Inhibitors: Implications for Treatment. Curr Infect Dis Rep 2012;14:155-60. [DOI: 10.1007/s11908-012-0236-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
19 Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, Hentrich M, Reinwald M, Salwender H, Schalk E, Schmidt-Hieber M, Weber T, Ostermann H. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann Hematol 2014;93:1083-95. [PMID: 24777705 DOI: 10.1007/s00277-014-2086-0] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
20 Ison MG. Optimizing antiviral therapy for influenza: understanding the evidence. Expert Rev Anti Infect Ther 2015;13:417-25. [PMID: 25695406 DOI: 10.1586/14787210.2015.1018183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
21 Saad M, Hayajneh W, Mubarak S, Yousef I, Awad H, Elbjeirami W, Rihani R. Clinical presentations and outcomes of influenza infection among hematology/oncology patients from a single cancer center: pandemic and post-pandemic seasons. Scand J Infect Dis. 2014;46:770-778. [PMID: 25134648 DOI: 10.3109/00365548.2014.943282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
22 Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C, Roccia-Rossi I, Stecher D, Carbone E, Laborde A, Efron E, Altclas J, Calmaggi A, Cozzi J. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res 2014;3:221. [PMID: 25469231 DOI: 10.12688/f1000research.5251.2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
23 Durani U, Dioverti Prono MV, Tosh PK, Patnaik M, Barreto JN, Tande AJ. Influenza infection in neutropenic adults. Infect Dis (Lond) 2017;49:141-6. [PMID: 27636702 DOI: 10.1080/23744235.2016.1231418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Cantwell L, Perkins J. Infectious Disease Emergencies in Oncology Patients. Emerg Med Clin North Am 2018;36:795-810. [PMID: 30297005 DOI: 10.1016/j.emc.2018.06.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
25 Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev 2019;32:e00042-19. [PMID: 31511250 DOI: 10.1128/CMR.00042-19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 13.7] [Reference Citation Analysis]
26 Jung S, Bae S, Ahn J, Kang S, Yang D, Kim Y, Kim H, Lee J. Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens. Int J Hematol 2013;97:382-7. [DOI: 10.1007/s12185-013-1270-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
27 Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, Lopez-Corral L, Crippa C, Fox ML, Grassi A, Jimenez MJ, Demir SK, Kwon M, Llamas CV, Lorenzo JLL, Mielke S, Orchard K, Porras RP, Vallisa D, Xhaard A, Knelange NS, Cedillo A, Kröger N, Piñana JL, Styczynski J. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia 2021. [PMID: 34079042 DOI: 10.1038/s41375-021-01302-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
28 Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 2019;25:800-9. [PMID: 30521974 DOI: 10.1016/j.bbmt.2018.11.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
29 Ivanyi P, Park-Simon T, Christiansen H, Gutzmer R, Vogel A, Heuser M, Golpon H, Hillemanns P, Haier J. Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis? Clin Exp Metastasis 2021;38:257-61. [PMID: 33759009 DOI: 10.1007/s10585-021-10083-1] [Reference Citation Analysis]
30 Yang K, Zhang N, Gao C, Qin H, Wang A, Song L. Risk factors for hospital-acquired influenza A and patient characteristics: a matched case-control study. BMC Infect Dis 2020;20:863. [PMID: 33213361 DOI: 10.1186/s12879-020-05580-9] [Reference Citation Analysis]
31 Seo S, Englund JA, Nguyen JT, Pukrittayakamee S, Lindegardh N, Tarning J, Tambyah PA, Renaud C, Went GT, de Jong MD, Boeckh MJ. Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics. Antivir Ther 2013;18:377-86. [PMID: 23264438 DOI: 10.3851/IMP2475] [Cited by in Crossref: 47] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
32 von Lilienfeld-Toal M, Berger A, Christopeit M, Hentrich M, Heussel CP, Kalkreuth J, Klein M, Kochanek M, Penack O, Hauf E, Rieger C, Silling G, Vehreschild M, Weber T, Wolf HH, Lehners N, Schalk E, Mayer K. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. Eur J Cancer 2016;67:200-12. [PMID: 27681877 DOI: 10.1016/j.ejca.2016.08.015] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
33 John MJ, Mathew A, Bhat S, Prabhakaran A, George B, John J. Post stem cell transplantation revaccination: A survey of the current practices in India. Vaccine 2018;36:2176-80. [DOI: 10.1016/j.vaccine.2018.02.084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
34 Kamboj M, Shah MK. Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:593-609. [PMID: 31005140 DOI: 10.1016/j.idc.2019.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
35 Wolfromm A, Porcher R, Legoff J, Peffault de Latour R, Xhaard A, de Fontbrune FS, Ribaud P, Bergeron A, Socié G, Robin M. Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome. Biol Blood Marrow Transplant 2014;20:1238-41. [PMID: 24732781 DOI: 10.1016/j.bbmt.2014.04.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
36 Hughes K, Middleton DB, Nowalk MP, Balasubramani GK, Martin ET, Gaglani M, Talbot HK, Patel MM, Ferdinands JM, Zimmerman RK, Silveira FP; HAIVEN Study Investigators. Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults. Clin Infect Dis 2021:ciaa1927. [PMID: 33388741 DOI: 10.1093/cid/ciaa1927] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Helanterä I, Janes R, Anttila VJ. Clinical efficacy of seasonal influenza vaccination: characteristics of two outbreaks of influenza A(H1N1) in immunocompromised patients. J Hosp Infect 2018;99:169-74. [PMID: 29225054 DOI: 10.1016/j.jhin.2017.12.003] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
38 Ljungman P. Enterovirus D68: a new threat to hematology patients? Blood 2015;125:1683-4. [PMID: 25766560 DOI: 10.1182/blood-2015-01-623785] [Reference Citation Analysis]
39 Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis 2013;15:219-32. [DOI: 10.1111/tid.12054] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
40 Popescu CM, Ursache AL, Feketea G, Bocsan C, Jimbu L, Mesaros O, Edwards M, Wang H, Berceanu I, Neaga A, Zdrenghea M. Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients? Microorganisms 2019;7:E521. [PMID: 31684063 DOI: 10.3390/microorganisms7110521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Vakil E, Evans SE. Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:97-111. [PMID: 28159165 DOI: 10.1016/j.ccm.2016.11.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
42 José RJ, Dickey BF, Sheshadri A. Airway disease in hematologic malignancies. Expert Rev Respir Med 2022. [PMID: 35176948 DOI: 10.1080/17476348.2022.2043746] [Reference Citation Analysis]
43 Waggoner JJ, Soda EA, Deresinski S. Rare and emerging viral infections in transplant recipients. Clin Infect Dis. 2013;57:1182-1188. [PMID: 23839998 DOI: 10.1093/cid/cit456] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
44 Ambati A, Boas LS, Ljungman P, Testa L, de Oliveira JF, Aoun M, Colturato V, Maeurer M, Machado CM. Evaluation of pretransplant influenza vaccination in hematopoietic SCT: a randomized prospective study. Bone Marrow Transplant 2015;50:858-64. [PMID: 25798680 DOI: 10.1038/bmt.2015.47] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
45 Lin R, Liu Q. Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation. J Hematol Oncol 2013;6:94. [PMID: 24341630 DOI: 10.1186/1756-8722-6-94] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
46 Liu Y, Wang Y, Mai H, Chen Y, Liu B, Liu Y, Ji Y, Cong X, Gao Y. Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015-2020 influenza seasons. Virol J 2022;19:11. [PMID: 35033116 DOI: 10.1186/s12985-021-01739-1] [Reference Citation Analysis]
47 Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I;  Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44-100. [PMID: 24311479 DOI: 10.1093/cid/cit684] [Cited by in Crossref: 419] [Cited by in F6Publishing: 350] [Article Influence: 46.6] [Reference Citation Analysis]
48 Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index. Biol Blood Marrow Transplant 2016;22:542-8. [PMID: 26638804 DOI: 10.1016/j.bbmt.2015.11.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
49 Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012;118:4627-4633. [PMID: 22359314 DOI: 10.1002/cncr.27447] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
50 Otto WR, Green A. Antiviral Therapeutics in Pediatric Transplant Recipients. Infectious Disease Clinics of North America 2022;36:125-46. [DOI: 10.1016/j.idc.2021.11.004] [Reference Citation Analysis]
51 Ljungman P. Vaccination of immunocompromised patients. Clin Microbiol Infect 2012;18 Suppl 5:93-9. [PMID: 23051059 DOI: 10.1111/j.1469-0691.2012.03971.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
52 Sim SA, Leung VKY, Ritchie D, Slavin MA, Sullivan SG, Teh BW. Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing. Biol Blood Marrow Transplant 2018;24:1490-6. [PMID: 29530766 DOI: 10.1016/j.bbmt.2018.03.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
53 Law N, Kumar D. Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs Aging 2017;34:743-54. [PMID: 28965331 DOI: 10.1007/s40266-017-0491-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
54 Rieger CT, Liss B, Mellinghoff S, Buchheidt D, Cornely OA, Egerer G, Heinz WJ, Hentrich M, Maschmeyer G, Mayer K, Sandherr M, Silling G, Ullmann A, Vehreschild MJGT, von Lilienfeld-Toal M, Wolf HH, Lehners N; German Society of Hematology and Medical Oncology Infectious Diseases Working Group (AGIHO). Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Oncol 2018;29:1354-65. [PMID: 29688266 DOI: 10.1093/annonc/mdy117] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
55 Fontana L, Strasfeld L. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:523-44. [PMID: 30940462 DOI: 10.1016/j.idc.2019.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
56 Bacigalupo A, Metafuni E, Amato V, Marquez Algaba E, Pagano L. Reducing infectious complications after allogeneic stem cell transplant. Expert Rev Hematol 2020;13:1235-51. [PMID: 32996342 DOI: 10.1080/17474086.2020.1831382] [Reference Citation Analysis]
57 Jaiswal SR, Bhagwati G, Soni M, Thatai A, Aiyer H, Chakrabarti S. Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation. Transpl Infect Dis 2020;22:e13309. [PMID: 32383345 DOI: 10.1111/tid.13309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses 2013;7 Suppl 3:60-6. [PMID: 24215383 DOI: 10.1111/irv.12170] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
59 Piñana J, Montoro J, Aznar C, Lorenzo I, Gómez MD, Guerreiro M, Carretero C, González-Barberá EM, Balaguer-Roselló A, Sanz R, Salavert M, Navarro D, Sanz MA, Sanz G, Sanz J. The clinical benefit of instituting a prospective clinical community-acquired respiratory virus surveillance program in allogeneic hematopoietic stem cell transplantation. J Infect 2020;80:333-41. [PMID: 31972212 DOI: 10.1016/j.jinf.2019.12.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
60 Dhédin N, Krivine A, Le Corre N, Mallet A, Lioure B, Bay JO, Rubio MT, Agape P, Thiébaut A, Le Goff J, Autran B, Ribaud P. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients. Vaccine 2014;32:585-91. [PMID: 24333120 DOI: 10.1016/j.vaccine.2013.11.073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
61 Jain A, Singh C, Dhawan R, Jindal N, Mohindra R, Lad D, Prakash G, Khadwal A, Suri V, Bhalla A, Kumari S, Varma N, John MJ, Mahapatra M, Malhotra P. How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India? Indian J Hematol Blood Transfus 2020;:1-11. [PMID: 32837051 DOI: 10.1007/s12288-020-01300-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
62 Atalla E, Kalligeros M, Mylona EK, Tsikala-Vafea M, Shehadeh F, Georgakas J, Mylonakis E. Impact of Influenza Infection Among Adult and Pediatric Populations With Hematologic Malignancy and Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Clin Ther 2021;43:e66-85. [PMID: 33812700 DOI: 10.1016/j.clinthera.2021.03.002] [Reference Citation Analysis]
63 Hu Y, Jiang Y, Liu S, Shen J, An Y. Phenotypes, Lung Microbiota and Cytokine Responses in Pneumonia After Hematopoietic Stem Cell Transplantation. J Inflamm Res 2021;14:6055-65. [PMID: 34824541 DOI: 10.2147/JIR.S338914] [Reference Citation Analysis]
64 Hijano DR, Maron G, Hayden RT. Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant. Front Microbiol 2018;9:3097. [PMID: 30619176 DOI: 10.3389/fmicb.2018.03097] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
65 Seo S, Waghmare A, Scott EM, Xie H, Kuypers JM, Hackman RC, Campbell AP, Choi SM, Leisenring WM, Jerome KR, Englund JA, Boeckh M. Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality. Haematologica 2017;102:1120-30. [PMID: 28183847 DOI: 10.3324/haematol.2016.153767] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
66 Gaundar SS, Blyth E, Clancy L, Simms RM, Ma CK, Gottlieb DJ. In vitro generation of influenza-specific polyfunctional CD4+ T cells suitable for adoptive immunotherapy. Cytotherapy 2012;14:182-93. [PMID: 21954837 DOI: 10.3109/14653249.2011.613932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
67 Cordero E, de la Torre-Cisneros J, Moreno A, Pérez-Romero P, Riera M. The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients. Enferm Infecc Microbiol Clin 2012;30 Suppl 4:38-42. [PMID: 23116791 DOI: 10.1016/S0213-005X(12)70103-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
68 Bitterman R, Eliakim-Raz N, Vinograd I, Zalmanovici Trestioreanu A, Leibovici L, Paul M. Influenza vaccines in immunosuppressed adults with cancer. Cochrane Database Syst Rev 2018;2:CD008983. [PMID: 29388675 DOI: 10.1002/14651858.CD008983.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
69 Bettoni da Cunha-Riehm C, Hildebrand V, Nathrath M, Metzler M, Suttorp M. Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment. Front Immunol. 2020;11:628. [PMID: 32362894 DOI: 10.3389/fimmu.2020.00628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Piñana JL, Pérez A, Montoro J, Giménez E, Gómez MD, Lorenzo I, Madrid S, González EM, Vinuesa V, Hernández-Boluda JC, Salavert M, Sanz G, Solano C, Sanz J, Navarro D. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study. Clin Infect Dis 2019;68:1894-903. [PMID: 30239624 DOI: 10.1093/cid/ciy792] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
71 Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med 2018;33:256-76. [PMID: 29506345 DOI: 10.3904/kjim.2018.036] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
72 Lee DG. Vaccination of hematopoietic stem cell transplantation recipients: perspective in Korea. Infect Chemother 2013;45:272-82. [PMID: 24396628 DOI: 10.3947/ic.2013.45.3.272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
73 Iioka F, Sada R, Maesako Y, Nakamura F, Ohno H. Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation. Int J Hematol 2012;96:364-9. [PMID: 22773299 DOI: 10.1007/s12185-012-1139-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
74 Lewalle P, Pochon C, Michallet M, Turlure P, Brissot E, Paillard C, Puyade M, Roth-Guepin G, Yakoub-Agha I, Chantepie S. [Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. Bull Cancer 2019;106:S23-34. [PMID: 30616839 DOI: 10.1016/j.bulcan.2018.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
75 Fernández-Ruiz M, Aguado JM. Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient - clinical spectrum and outcome. Curr Opin Infect Dis 2021;34:654-62. [PMID: 34751184 DOI: 10.1097/QCO.0000000000000790] [Reference Citation Analysis]
76 Tsigrelis C, Ljungman P. Vaccinations in patients with hematological malignancies. Blood Rev 2016;30:139-47. [PMID: 26602587 DOI: 10.1016/j.blre.2015.10.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
77 Ison MG. Clinical use of approved influenza antivirals: therapy and prophylaxis. Influenza Other Respir Viruses 2013;7 Suppl 1:7-13. [PMID: 23279892 DOI: 10.1111/irv.12046] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
78 Yue MC, Collins JT, Subramoniapillai E, Kennedy GA. Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit. Asia Pac J Clin Oncol 2017;13:37-43. [PMID: 27730741 DOI: 10.1111/ajco.12565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
79 Ambati A, Einarsdottir S, Magalhaes I, Poiret T, Bodenstein R, Leblanc K, Brune M, Maeurer M, Ljungman P. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients. Transpl Infect Dis 2015;17:371-9. [DOI: 10.1111/tid.12382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
80 Miller PDE, de Silva TI, Skinner R, Gilleece M, Peniket A, Hamblin A, Greenfield D, Anthias C, Peggs K, Madrigal A, Snowden JA; on behalf of the BSBMT Clinical Trials Committee. Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes. Bone Marrow Transplant 2017;52:775-7. [DOI: 10.1038/bmt.2016.362] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]